Literature DB >> 26545874

Cough in interstitial lung disease.

Justin Garner1, Peter M George2, Elisabetta Renzoni2.   

Abstract

Cough in the context of interstitial lung disease (ILD) has not been the focus of many studies. However, chronic cough has a major impact on quality of life in a significant proportion of patients with ILD. For the purpose of this review, we have chosen to highlight some of the more frequently encountered diffuse lung diseases including idiopathic pulmonary fibrosis, sarcoidosis, hypersensitivity pneumonitis and systemic sclerosis associated ILD. Many of the underlying mechanisms remain speculative and further research is now required to elucidate the complex pathways involved in the pathogenesis of chronic cough in ILD. This will hopefully pave the way for the identification of new therapeutic agents to alleviate this distressing and often intractable symptom.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cough; Interstitial lung disease; Lung fibrosis; Mechanisms

Mesh:

Year:  2015        PMID: 26545874     DOI: 10.1016/j.pupt.2015.10.009

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  3 in total

1.  Clinical significance of self-reported cough intensity and frequency in patients with interstitial lung disease: a cross-sectional study.

Authors:  Ryuhei Sato; Tomohiro Handa; Hisako Matsumoto; Takeshi Kubo; Toyohiro Hirai
Journal:  BMC Pulm Med       Date:  2019-12-16       Impact factor: 3.317

2.  Management of cough in patients with idiopathic interstitial lung diseases in primary care.

Authors:  Diana C Sanchez-Ramirez; Leanne Kosowan; Alex Singer
Journal:  Chron Respir Dis       Date:  2022 Jan-Dec       Impact factor: 2.444

3.  Antitussive Effect of a Chest Band in Patients with Interstitial Lung Disease: The Preliminary Results from a Pre-post Intervention Study.

Authors:  Ryuhei Sato; Tomohiro Handa; Hisako Matsumoto; Kota Hirai; Noriyuki Ohkura; Takeshi Kubo; Toyohiro Hirai
Journal:  Intern Med       Date:  2021-12-01       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.